Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study; response to comments
J Cyst Fibros
.
2017 Nov;16(6):e21.
doi: 10.1016/j.jcf.2017.09.008.
Epub 2017 Oct 25.
Authors
H L Barr
1
,
N Halliday
2
,
D A Barrett
3
,
P Williams
2
,
D L Forrester
4
,
D Peckham
5
,
K Williams
5
,
A R Smyth
6
,
D Honeybourne
7
,
J L Whitehouse
7
,
E F Nash
7
,
J Dewar
8
,
A Clayton
8
,
A J Knox
4
,
M Cámara
2
,
A W Fogarty
9
Affiliations
1
Division of Respiratory Medicine, University of Nottingham, City Hospital Campus, Nottingham, UK. Electronic address:
[email protected]
.
2
School of Life Sciences, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, UK.
3
Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, UK.
4
Division of Respiratory Medicine, University of Nottingham, City Hospital Campus, Nottingham, UK.
5
Leeds Adult Cystic Fibrosis Centre, St James's University Hospital, Leeds, UK.
6
Division of Child Health, Obstetrics and Gynaecology, University of Nottingham, UK.
7
West Midlands Adult CF Centre, Heart of England, NHS Foundation Trust, Birmingham, UK.
8
Wolfson Cystic Fibrosis Centre, Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.
9
Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Building, University of Nottingham, Nottingham, UK.
PMID:
29079141
DOI:
10.1016/j.jcf.2017.09.008
No abstract available
Publication types
Letter
Comment
MeSH terms
Cystic Fibrosis*
Humans
Longitudinal Studies
Prognosis
Pseudomonas Infections
Pseudomonas aeruginosa*
Quinolones
Substances
Quinolones
Grants and funding
G0801558/MRC_/Medical Research Council/United Kingdom